Blair William & CO Dynavax Technologies Corp Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Blair William & CO holds 2,350,708 shares of DVAX stock, worth $29.2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,350,708

Previous 2,360,904 0.43%

Holding current value

$29.2 Million

Previous $26.5 Million 1.23%

% of portfolio

0.08%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.05 - $11.61 $102,469 - $118,375	-10,196 Reduced 0.43%	2,350,708 $26.2 Million
Q2 2024 Aug 12, 2024	SELL	$10.73 - $12.58 $438,642 - $514,270	-40,880 Reduced 1.7%	2,360,904 $26.5 Million
Q1 2024 May 09, 2024	SELL	$11.7 - $14.98 $86,942 - $111,316	-7,431 Reduced 0.31%	2,401,784 $29.8 Million
Q4 2023 Feb 12, 2024	SELL	$13.09 - $14.98 $798,175 - $913,420	-60,976 Reduced 2.47%	2,409,215 $33.7 Million
Q3 2023 Nov 09, 2023	BUY	$12.64 - $14.99 $190,345 - $225,734	15,059 Added 0.61%	2,470,191 $36.5 Million
Q2 2023 Aug 11, 2023	SELL	$9.85 - $13.17 $735,666 - $983,627	-74,687 Reduced 2.95%	2,455,132 $31.7 Million
Q1 2023 May 12, 2023	BUY	$9.44 - $11.88 $411,112 - $517,374	43,550 Added 1.75%	2,529,819 $24.8 Million
Q4 2022 Feb 10, 2023	BUY	$10.27 - $13.29 $262,172 - $339,267	25,528 Added 1.04%	2,486,269 $26.5 Million
Q3 2022 Nov 09, 2022	SELL	$9.93 - $17.44 $643,315 - $1.13 Million	-64,785 Reduced 2.57%	2,460,741 $25.7 Million
Q2 2022 Aug 10, 2022	SELL	$7.45 - $12.83 $193,118 - $332,579	-25,922 Reduced 1.02%	2,525,526 $31.8 Million
Q1 2022 May 13, 2022	BUY	$9.75 - $14.44 $3.01 Million - $4.46 Million	308,553 Added 13.76%	2,551,448 $27.7 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $110,614 - $175,875	-8,399 Reduced 0.37%	2,242,895 $31.6 Million
Q3 2021 Nov 12, 2021	SELL	$9.16 - $19.83 $1.14 Million - $2.46 Million	-123,921 Reduced 5.22%	2,251,294 $43.2 Million
Q2 2021 Aug 12, 2021	BUY	$7.25 - $10.99 $811,420 - $1.23 Million	111,920 Added 4.95%	2,375,215 $23.4 Million
Q1 2021 May 13, 2021	BUY	$4.57 - $11.18 $364,877 - $892,633	79,842 Added 3.66%	2,263,295 $22.2 Million
Q4 2020 Feb 09, 2021	BUY	$3.73 - $5.6 $545,493 - $818,972	146,245 Added 7.18%	2,183,453 $9.72 Million
Q3 2020 Nov 06, 2020	BUY	$4.32 - $11.7 $44,647 - $120,919	10,335 Added 0.51%	2,037,208 $8.8 Million
Q2 2020 Aug 12, 2020	BUY	$2.94 - $9.1 $81,643 - $252,707	27,770 Added 1.39%	2,026,873 $18 Million
Q1 2020 May 11, 2020	BUY	$2.27 - $6.2 $712,657 - $1.95 Million	313,946 Added 18.63%	1,999,103 $7.06 Million
Q4 2019 Feb 13, 2020	BUY	$3.46 - $6.93 $259,790 - $520,332	75,084 Added 4.66%	1,685,157 $9.64 Million
Q3 2019 Nov 12, 2019	BUY	$2.69 - $4.85 $1.58 Million - $2.85 Million	587,211 Added 57.41%	1,610,073 $5.76 Million
Q2 2019 Aug 13, 2019	BUY	$3.65 - $7.89 $97,305 - $210,339	26,659 Added 2.68%	1,022,862 $4.08 Million
Q1 2019 May 14, 2019	BUY	$7.08 - $12.09 $217,122 - $370,764	30,667 Added 3.18%	996,203 $7.28 Million
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $433,178 - $706,708	53,216 Added 5.83%	965,536 $8.84 Million
Q3 2018 Nov 13, 2018	BUY	$11.85 - $16.0 $132,565 - $178,992	11,187 Added 1.24%	912,320 $11.3 Million
Q2 2018 Aug 13, 2018	SELL	$15.15 - $20.75 $5.31 Million - $7.28 Million	-350,738 Reduced 28.02%	901,133 $13.7 Million
Q1 2018 May 15, 2018	SELL	$14.65 - $19.9 $10.7 Million - $14.5 Million	-728,655 Reduced 36.79%	1,251,871 $24.9 Million
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $34.3 Million - $47.7 Million	1,980,526	1,980,526 $37 Million

Others Institutions Holding DVAX

# of Institutions

274

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account